3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1
1
Status
Recruiting
10
Completed
7
Active not recruiting
5
Withdrawn
4
Terminated
4
Unknown
3
Not yet recruiting
1
No longer available
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
3
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Non-small Cell Lung Cancer Metastatic
1
Neoplasms
1
Lung Neoplasms
1
Interventions
Carboplatin
132
Cisplatin
129
Pemetrexed
114
Docetaxel
81
Drug Therapy
62
Gefitinib
57
anlotinib
55
Gemcitabine
55
Erlotinib Hydrochloride
55
Radiotherapy
48
Bevacizumab
48
pembrolizumab
47
Paclitaxel
47
Etoposide
44
apatinib
42
icotinib
41
camrelizumab
39
osimertinib
36
Nivolumab
33
Vinorelbine
31
Radiosurgery
30
sintilimab
29
durvalumab
25
aumolertinib
25
endostar protein
24
atezolizumab
22
Endostatins
22
toripalimab
19
Blood Specimen Collection
19
tislelizumab
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Unknown
×
sotorasib
×
Thoracic
×
Clear all
NCT06127940
2023-11-13
K-SAB
Karolinska University Hospital
Phase 1
Unknown
20 enrolled
NCT05311709
2023-11-09
SOLUCOM
Vestre Viken Hospital Trust
Phase 2
Unknown
100 enrolled
NCT05451056
2022-07-11
breakthrough
Yonsei University
Phase 2
Unknown
37 enrolled